• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dendreon Corp

+ Add to Watchlist

DNDN:US

2.6500 USD 0.0400 1.49%

As of 20:10:00 ET on 04/17/2014.

Company Profile for Dendreon Corp (DNDN)

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.

Contact Information

Dendreon Corp

1301 2nd Avenue
Seattle, WA 98101
United States
Phone: 1-206-256-4545
Fax: 1-206-256-0571

Key Executives for Dendreon Corp (DNDN)

John H JohnsonChairman/President/CEOBill JenkinsonChief Marketing Officer
Gregory R CoxInterim CFO/VP:FinanceSilvio PachecoChief Customer Officer
Andrew S SandlerExec VP/Chief Medical OfficerLindsay RoccoExec VP:Corporate Communications
William MonteithExec VP:Technical OperationsRobert CrottyVP/Interim Secy & Gen Cnsl

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil